StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > The next week will be monumental.

<< Previous

Bullboard Posts

Next >>

Comment by Bucky86on Aug 09, 2020 12:58pm

157 Views

Post# 31384594

RE:RE:RE:RE:RE:RE:The next week will be monumental.

Well said CBG. I agree. Covid testing is a temporary phase in this company's evolution. That being said if Q2 #s are bad...ie show no real significant* uptick I'd be skeptical that Q3 will be outstanding either. My point is we always look ahead to the next Q and the next Q etc. If I'm not wowed by June #s in particular I'll predict an average Q3 also.... Just my opinion. The time is now for results, forget Q3

<< Previous

Bullboard Posts

Next >>

Quebecor achieves all Freedom Mobile acquisition commitments